Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nidhi Wali, Andre Renzaho, Xia Wang, Bethany Atkins & Debi Bhattacharya. (2021) Do interventions to improve adherence to antiretroviral therapy recognise diversity? A systematic review. AIDS Care 33:11, pages 1379-1393.
Read now
Read now
Karolina Akinosoglou, Stefania Antonopoulou, Ioannis Katsarolis & Charalambos A. Gogos. (2021) Patient-reported outcomes in HIV clinical trials evaluating antiretroviral treatment: a systematic review. AIDS Care 33:9, pages 1118-1126.
Read now
Read now
Franco Maggiolo, Alessandra Bandera, Stefano Bonora, Marco Borderi, Andrea Calcagno, Annamaria Cattelan, Antonella Cingolani, Nicola Gianotti, Miriam Lichtner, Sergio Lo Caputo, Giordano Madeddu, Paolo Maggi, Giulia Carla Marchetti, Renato Maserati, Silvia Nozza, Stefano Rusconi, Maurizio Zazzi & Antonio Di Biagio. (2021) Enhancing care for people living with HIV: current and future monitoring approaches. Expert Review of Anti-infective Therapy 19:4, pages 443-456.
Read now
Read now
Frederick Altice, Obaro Evuarherhe, Sophie Shina, Gemma Carter & Anne Christine Beaubrun. (2019) Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Preference and Adherence 13, pages 475-490.
Read now
Read now
Articles from other publishers (11)
Federico Lucantoni, Ana M. Benedicto, Aleksandra Gruevska, Ángela B. Moragrega, Isabel Fuster-Martínez, Juan V. Esplugues, Ana Blas-García & Nadezda Apostolova. (2022) Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less. Cell Death & Disease 13:4.
Crossref
Crossref
Renee El-Krab & Seth C. Kalichman. (2021) Alcohol-Antiretroviral Therapy Interactive Toxicity Beliefs and Intentional Medication Nonadherence: Review of Research with Implications for Interventions. AIDS and Behavior 25:S3, pages 251-264.
Crossref
Crossref
Richard Leong, Leon Owusu, Jerrica Tang, Neeraj John, Kira E Voyer, Emma Gargala, Benjamin Daigler, Qing Ma, Gene D Morse & Raymond Cha. (2021) Patient-reported outcomes for HIV: the future of long-acting injectables and antiretroviral therapy evaluations. Future Virology 16:8, pages 543-553.
Crossref
Crossref
Anthony Allen Reeves, Andrea V Fuentes, Joshua Caballero, Jennifer E Thomas, Juan F Mosley II & Catherine Harrington. (2021) Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis. Sexually Transmitted Infections 97:4, pages 261-267.
Crossref
Crossref
Andrea Antinori, Maria V. Cossu, Barbara Menzaghi, Gaetana Sterrantino, Nicola Squillace, Valentina Di Cristo, Annamaria Cattelan, Emanuele Focà, Antonella Castagna, Giancarlo Orofino, Daniela Valenti, Gabriella D’Ettore, Lucia Aprea, Sergio Ferrara, Maria E. Locatelli, Giordano Madeddu, Emanuele Pontali, Paolo Scerbo, Barbara Rossetti, Alessia Uglietti, Roberta Termini, Francesco Rucci, Andrea Gori & Daniela Mancusi. (2020) Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. The Patient - Patient-Centered Outcomes Research 13:3, pages 375-387.
Crossref
Crossref
Alberto Martí-Rodrigo, Fernando Alegre, Ángela B Moragrega, Francisco García-García, Pablo Martí-Rodrigo, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Nadezda Apostolova, Juan V Esplugues & Ana Blas-García. (2020) Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells. Gut 69:5, pages 920-932.
Crossref
Crossref
D. Podzamczer, N. Rozas, P. Domingo, C. Miralles, E. Van den Eynde, A. Romero, E. Deig, H. Knobel, J. Pasquau, A. Antela, B. Clotet, P. Geijo, E. Rodríguez de Castro, M.A. Casado, A. Muñoz, A. Casado & for the PRO-STR STUDY GROUP. (2019) Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study. Current HIV Research 16:6, pages 425-435.
Crossref
Crossref
Marineide Gonçalves de Melo, Ivana Varella, Pamina M. Gorbach, Eduardo Sprinz, Breno Santos, Tauí de Melo Rocha, Mariana Simon, Marcelo Almeida, Rita Lira, Maria Cristina Chaves, Zoe Baker, Tara Kerin & Karin Nielsen-Saines. (2019) Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil. PLOS ONE 14:2, pages e0212744.
Crossref
Crossref
L Taramasso, A Di Biagio, F Maggiolo, A Tavelli, S Lo Caputo, S Bonora, M Zaccarelli, P Caramello, A Costantini, C Viscoli, A d'Arminio Monforte & A Cozzi-Lepri. (2018) First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison. HIV Medicine 19:7, pages 475-484.
Crossref
Crossref
Krista J. Siefried, Limin Mao, Stephen Kerr, Lucette A. Cysique, Thomas M. Gates, John McAllister, Anthony Maynard, John de Wit & Andrew Carr. (2017) Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression. PLOS ONE 12:4, pages e0174613.
Crossref
Crossref
Laurent Cotte, Tristan Ferry, Pascal Pugliese, Marc-Antoine Valantin, Clotilde Allavena, André Cabié, Isabelle Poizot-Martin, David Rey, Claudine Duvivier, Antoine Cheret, Pierre Dellamonica, Pierre Pradat & Jean-Jacques Parienti. (2017) Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study. PLOS ONE 12:2, pages e0170661.
Crossref
Crossref